Sign In
Buy LTRN
$3.40
-0.340 (-9.09%)
At Close: Jun 03, 2026
Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel DNA-Damaging Agent with Anticancer Properties
07:00am, Wednesday, 17'th Mar 2021
DALLAS, March 17, 2021 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transfor
Lantern Pharma Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
09:00am, Friday, 12'th Mar 2021
DALLAS, March 12, 2021 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("A.I.") platform to transf
Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q4 2020 Results - Earnings Call Transcript
09:55pm, Wednesday, 10'th Mar 2021
Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q4 2020 Results - Earnings Call Transcript
Lantern Pharma Reports Fourth Quarter and Year End 2020 Financial Results and Operational Highlights
04:00pm, Wednesday, 10'th Mar 2021
DALLAS, March 10, 2021 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("A.I.") platform to transfo
Predictive Oncology: Potentially Undervalued Drug Discovery AI Company
03:11pm, Wednesday, 24'th Feb 2021
Predictive Oncology: Potentially Undervalued Drug Discovery AI Company
Lantern Pharma Announces Pricing of $60 Million Public Offering
09:30pm, Thursday, 14'th Jan 2021
DALLAS, Jan. 14, 2021 /PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform cancer drug
Lantern Pharma (LTRN) Investor Presentation - Slideshow
01:43pm, Friday, 04'th Sep 2020
The following slide deck was published by Lantern Pharma Inc. in conjunction with this event..
Wall Street Breakfast: The Week Ahead
07:40am, Sunday, 30'th Aug 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Nvidia, Intel And Zoom Look To Dazzle
08:00am, Saturday, 29'th Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Big Data Analytics Market 2020 Global Significant Growth,Technological Advancement & Opportunities To 2025
07:28am, Friday, 21'st Aug 2020
WiseGuyReports.com Publish A New Market Research Report on –“ Big Data Analytics Market 2020 Global Significant Growth,Technological Advancement &
AI Is Booming: Here Are 3 Stocks Analysts Are Betting On
05:29pm, Tuesday, 18'th Aug 2020
Artificial Intelligence isn’t just science fiction anymore. The technology is maturing, and AI is allowing machines to take an ever-growing role is more and more sectors of our digital world. Financ
Lantern Pharma Interview to Air on Bloomberg International on the RedChip Money Report
06:25pm, Friday, 14'th Aug 2020
Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery and development, and identify pat
LD Micro - Announces Preliminary List of Presenters for the LD 500
01:00pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Insights on the Culinary Tourism Global Market to 2027 - Opportunity Analysis and Industry Forecast - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
10:57am, Thursday, 30'th Jul 2020
Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery and development, and identify pat
